中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2010年
47期
3339-3342
,共4页
方礼明%张亚军%张军%黄楠%林华刚%李兵%郑继元
方禮明%張亞軍%張軍%黃楠%林華剛%李兵%鄭繼元
방례명%장아군%장군%황남%림화강%리병%정계원
脊柱融合术%腰椎%椎间盘移位
脊柱融閤術%腰椎%椎間盤移位
척주융합술%요추%추간반이위
Spinal fusion%Lumbar vertebrae%Intervertebral disc displacement
目的 分析改良经椎间孔椎体间融合术(TLIF)治疗腰椎间盘突出症的手术效果.方法 对2005年7月至2008年6月改良TLIF治疗腰椎间盘突出症46例随访资料完整的病例进行回顾性研究.其中男32例,女14例,年龄27~65岁,平均47岁,病程4~18年,平均7.5年.单节段18例,其中L3/4 5例,L4/5 8例,L5/S1 5例,同时合并其他节段退行性变28例.术前视觉模拟疼痛评分(VAS)为(8.9±1.3)分,Oswestry功能障碍指数(ODI)为(57.3±5.2)分.患者均经至少3个月正规非手术治疗后无明显疗效.结果 46例获随访12~30个月,平均20个月.单侧椎间孔入路减压38例,双侧椎间孔入路减压8例.手术时间120~180 min,平均160 min;术中出血量400~800 ml,平均550 ml.所有患者伤口一期愈合,均未出现并发症.术后3个月时VAS和ODI评分分别为(2.0±0.4)分和(15.2±3.4)分,与术前比较差异有统计学意义(P<O.05);VAS评分改善率为(80.1±4.7)%,ODI评分改善率为(73.6±2.8)%.术后12个月内椎体间均骨性融合,融合率100%.疗效评价:优34例,良8例,可4例,优良率91.3%.术后3 d佩戴支具下地活动,3个月患者基本恢复正常工作.结论 改良经椎间孔椎间融合术是治疗腰椎间盘突出症的一种有效方法,需要术前检查与临床症状密切结合制定具体手术方案.
目的 分析改良經椎間孔椎體間融閤術(TLIF)治療腰椎間盤突齣癥的手術效果.方法 對2005年7月至2008年6月改良TLIF治療腰椎間盤突齣癥46例隨訪資料完整的病例進行迴顧性研究.其中男32例,女14例,年齡27~65歲,平均47歲,病程4~18年,平均7.5年.單節段18例,其中L3/4 5例,L4/5 8例,L5/S1 5例,同時閤併其他節段退行性變28例.術前視覺模擬疼痛評分(VAS)為(8.9±1.3)分,Oswestry功能障礙指數(ODI)為(57.3±5.2)分.患者均經至少3箇月正規非手術治療後無明顯療效.結果 46例穫隨訪12~30箇月,平均20箇月.單側椎間孔入路減壓38例,雙側椎間孔入路減壓8例.手術時間120~180 min,平均160 min;術中齣血量400~800 ml,平均550 ml.所有患者傷口一期愈閤,均未齣現併髮癥.術後3箇月時VAS和ODI評分分彆為(2.0±0.4)分和(15.2±3.4)分,與術前比較差異有統計學意義(P<O.05);VAS評分改善率為(80.1±4.7)%,ODI評分改善率為(73.6±2.8)%.術後12箇月內椎體間均骨性融閤,融閤率100%.療效評價:優34例,良8例,可4例,優良率91.3%.術後3 d珮戴支具下地活動,3箇月患者基本恢複正常工作.結論 改良經椎間孔椎間融閤術是治療腰椎間盤突齣癥的一種有效方法,需要術前檢查與臨床癥狀密切結閤製定具體手術方案.
목적 분석개량경추간공추체간융합술(TLIF)치료요추간반돌출증적수술효과.방법 대2005년7월지2008년6월개량TLIF치료요추간반돌출증46례수방자료완정적병례진행회고성연구.기중남32례,녀14례,년령27~65세,평균47세,병정4~18년,평균7.5년.단절단18례,기중L3/4 5례,L4/5 8례,L5/S1 5례,동시합병기타절단퇴행성변28례.술전시각모의동통평분(VAS)위(8.9±1.3)분,Oswestry공능장애지수(ODI)위(57.3±5.2)분.환자균경지소3개월정규비수술치료후무명현료효.결과 46례획수방12~30개월,평균20개월.단측추간공입로감압38례,쌍측추간공입로감압8례.수술시간120~180 min,평균160 min;술중출혈량400~800 ml,평균550 ml.소유환자상구일기유합,균미출현병발증.술후3개월시VAS화ODI평분분별위(2.0±0.4)분화(15.2±3.4)분,여술전비교차이유통계학의의(P<O.05);VAS평분개선솔위(80.1±4.7)%,ODI평분개선솔위(73.6±2.8)%.술후12개월내추체간균골성융합,융합솔100%.료효평개:우34례,량8례,가4례,우량솔91.3%.술후3 d패대지구하지활동,3개월환자기본회복정상공작.결론 개량경추간공추간융합술시치료요추간반돌출증적일충유효방법,수요술전검사여림상증상밀절결합제정구체수술방안.
Objective To evaluate the outcomes of modified transforaminal lumbar interbody fusion in patients with lumbar disc herniation. Methods Forty-six cases of lumbar disc hemiation were treated by modified transforaminal lumbar interbody fusion. There were 32 males and 14 females with a mean age of 47 years old (range :27 - 65). The mean course of disease was 7.5 years (range :4 - 18). Eighteen cases were of single-level lumbar disc herniation, including L3/4 (n = 5), L4/5 (n = 8) and L5/S1 (n = 5).There were 28 cases with lumbar degenerative diseases at other levels. Preoperatively, the score of visual analogue scale (VAS) was 8. 9±1.3 and the score of Oswestry disability index (ODI) was 57. 3 ±5.2. All patients received a normal conservative treatment for at least 3 months with no therapeutic effect at preoperation. Results Forty-six cases had an average follow-up of 20 months (range:12-20). The operative duration was an average of 160 minutes (range: 120 - 180). And the average volume of intra-operative blood loss was 550 ml (range:400-800). There was no severe complication. The symptoms became stable after three months. At 3 months postoperatively, the score of VAS was 2. 0 ± 0. 4 and the score of ODI 15. 2 ±3.4. And there were significant differences between preoperative and postoperative values (P<0. 05). The improvement rates of postoperative VAS and ODI were(80. 1 ±4. 7)%and(73.6 ±2. 8)% respectively. All patients achieved lumbar interbody bone fusion at 12 months post-operation with a fusion rate of 100%. For the therapeutic effect, 34 cases were regarded as excellent, 8 good and 4 fair with an excellent/good rate of 91.3%. All patients began to walk with orthosis after 3 days and resumed their jobs and normal lives after 3 months. Conclusion Modified transforaminal lumbar interbody fusion is effective for the treatment of lumbar disc hemiation. Making a detailed operative plan on the basis of preoperative images and symptoms is essential.